BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,248,098 | +13.1% | 271,545 | +36.6% | 0.01% | +16.7% |
| Q2 2023 | $9,059,050 | +17.3% | 198,838 | +4.4% | 0.01% | 0.0% |
| Q1 2023 | $7,722,167 | -22.8% | 190,389 | -2.9% | 0.01% | -33.3% |
| Q4 2022 | $9,996,824 | -6.6% | 196,132 | -1.3% | 0.01% | -10.0% |
| Q3 2022 | $10,705,000 | -9.3% | 198,761 | +8.1% | 0.01% | -9.1% |
| Q2 2022 | $11,809,000 | -15.8% | 183,853 | +1.7% | 0.01% | -8.3% |
| Q1 2022 | $14,020,000 | -9.8% | 180,809 | -0.2% | 0.01% | -7.7% |
| Q4 2021 | $15,549,000 | +7.1% | 181,140 | +0.4% | 0.01% | -7.1% |
| Q3 2021 | $14,517,000 | +1.8% | 180,489 | +1.9% | 0.01% | 0.0% |
| Q2 2021 | $14,258,000 | +1.9% | 177,115 | +6.8% | 0.01% | -12.5% |
| Q1 2021 | $13,990,000 | +25.6% | 165,871 | +19.5% | 0.02% | +14.3% |
| Q4 2020 | $11,138,000 | +14.0% | 138,803 | +14.2% | 0.01% | -6.7% |
| Q3 2020 | $9,774,000 | -4.7% | 121,533 | +2.0% | 0.02% | -16.7% |
| Q2 2020 | $10,258,000 | +18.9% | 119,145 | +12.1% | 0.02% | -5.3% |
| Q1 2020 | $8,627,000 | -5.8% | 106,262 | -3.0% | 0.02% | +11.8% |
| Q4 2019 | $9,157,000 | +15.0% | 109,502 | +20.2% | 0.02% | +6.2% |
| Q3 2019 | $7,965,000 | +2.7% | 91,063 | -3.9% | 0.02% | -5.9% |
| Q2 2019 | $7,759,000 | +3.8% | 94,737 | +3.0% | 0.02% | 0.0% |
| Q1 2019 | $7,477,000 | +24.3% | 91,963 | +0.7% | 0.02% | +6.2% |
| Q4 2018 | $6,014,000 | -14.2% | 91,365 | +0.5% | 0.02% | -5.9% |
| Q3 2018 | $7,007,000 | -2.1% | 90,891 | -6.3% | 0.02% | -10.5% |
| Q2 2018 | $7,160,000 | +22.7% | 96,964 | +8.1% | 0.02% | +18.8% |
| Q1 2018 | $5,833,000 | +31.0% | 89,676 | +30.2% | 0.02% | +14.3% |
| Q4 2017 | $4,451,000 | -12.1% | 68,861 | -14.6% | 0.01% | -22.2% |
| Q3 2017 | $5,061,000 | +4.1% | 80,659 | +0.5% | 0.02% | 0.0% |
| Q2 2017 | $4,860,000 | +179.8% | 80,280 | +141.7% | 0.02% | +50.0% |
| Q1 2017 | $1,737,000 | +196.4% | 33,212 | +151.7% | 0.01% | +200.0% |
| Q4 2016 | $586,000 | -17.6% | 13,196 | -12.2% | 0.00% | -42.9% |
| Q3 2016 | $711,000 | +11.1% | 15,032 | +8.1% | 0.01% | +40.0% |
| Q2 2016 | $640,000 | -82.6% | 13,908 | -84.4% | 0.01% | -50.0% |
| Q1 2016 | $3,676,000 | +4.0% | 88,976 | -6.1% | 0.01% | 0.0% |
| Q4 2015 | $3,535,000 | +93.9% | 94,713 | +73.1% | 0.01% | 0.0% |
| Q3 2015 | $1,823,000 | -32.9% | 54,730 | -23.4% | 0.01% | -28.6% |
| Q2 2015 | $2,716,000 | -58.6% | 71,406 | -26.5% | 0.01% | -58.8% |
| Q1 2015 | $6,562,000 | -9.9% | 97,160 | -2.2% | 0.03% | -15.0% |
| Q4 2014 | $7,280,000 | +5.2% | 99,329 | +2.6% | 0.04% | -2.4% |
| Q3 2014 | $6,922,000 | +2.5% | 96,798 | +3.7% | 0.04% | +5.1% |
| Q2 2014 | $6,750,000 | -5.2% | 93,360 | -3.6% | 0.04% | -11.4% |
| Q1 2014 | $7,123,000 | -1.2% | 96,810 | -6.6% | 0.04% | -2.2% |
| Q4 2013 | $7,208,000 | +42.8% | 103,641 | +36.5% | 0.04% | +32.4% |
| Q3 2013 | $5,049,000 | +1.4% | 75,944 | +5.7% | 0.03% | -5.6% |
| Q2 2013 | $4,979,000 | – | 71,874 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |